Zebrafish Crabp2a and Crabp2b are essential for expression of hoxb4 and hoxb5 in the hindbrain.
crabp2a mRNA was detected in total RNA extracted from whole adult zebrafish, adult zebrafish muscle, testes, and skin and to a lesser extent in heart, ovary and brain.
Chromosome mapping of CRABP1 AND CRABP2 in swine.
Semiquantitative and quantitative analyses of the markers RARA and CRABP2 indicate their potential as biomarkers for tumor progression and their participation in nephroblastoma tumorigenesis
These data suggest a retinoic acid-independent, non-tumor suppressor role of CRABP2 for the survival of Malignant peripheral nerve sheath tumor (MPNST) cells in vitro. Targeting CRABP2 overexpression may represent a unique approach for the treatment of human MPNST.
A high expression ratio between FABP5 and CRABPII may be related to CP tumor recurrence and ATRA could be a potential therapeutic agent for CP chemotherapy.
Holo-CRABPs had higher affinity for CYP26B1 than free atRA, but both apo-CRABPs(CRABP-I and CRABP-II ) inhibited the formation of 4-OH-RA by CYP26B1.
reducing CRABP2 levels may enhance the therapeutic index of Retinoic acid in glioblastoma multiforme patients
in esophageal squamous carcinogenesis by significantly inhibiting cell growth, inducing cell apoptosis and blocking cell metastasis both in vitro and in vivo
The anticarcinogenic activities of CRABP2 are mediated by both HuR and RAR.
CBX3 and CRABP2 expression was markedly increased in lung cancer tissues
we demonstrated significant changes in CRABP1 and CRABP2 expression in non-small cell lung cancer samples
Reengineering of cellular retinoic acid binding protein II (CRABPII) to be capable of binding retinal as a protonated Schiff base is described
CRABP2 controls mRNA stabilization by HuR.
Factors involved in the retinoid pathway, in particular upregulation of CRBP, CRABP1 and CRABP2, also showed differential expression in tumors with different histological subtypes
overexpression of CRABP-II is a late event of pancreatic carcinogenesis, and it could be used as a diagnostic marker
all three proteins (RDH10, RALDH2, and CRABP2) appeared to be required for ATRA production induced by activation of PPARgamma
E-FABP showed high exp ression in NSCLC, and the increased E-FABP expression may involved in the occurrence and development of NSCLC
Hypermethylation in the CpG island of the CRABP2 gene is associated with astrocytic gliomas.
Aberrant methylation in CRABP-II reduces the expression of CRABP-II that in turn confers retinoic acid resistance in medulloblastoma cells.
Low CRABP2 is associated with pancreatic ductal adenocarcinoma.
Nuclear translocation of cellular retinoic acid-binding protein II is regulated by retinoic acid-controlled SUMOylation
Trophoblast spheroids cocultured with endometrial cells overexpressing CRABP2 are defective in expansion and exhibit apoptosis, suggesting that CRABP2 is involved in abnormal endometrium-trophoblast interaction, leading to implantation failure.
The anticarcinogenic activities of CRABP2 are mediated by both HuR and RAR.
Results show that acetylation status of CRABPII directly influences embryonic stem cell differentiation in response to retinoic acid.
CRABP2 controls mRNA stabilization by HuR.
all three proteins (RDH10, RALDH2, and CRABP2) appeared to be required for ATRA production induced by activation of PPARgamma
CRABP2 promotes myoblast differentiation and is modulated by the transcription factors MyoD and Sp1 in C2C12 cells.
observations emphasize the important role of CRABP-II in regulating the transcriptional activity of RA through RAR, and they demonstrate that repression of this gene is critical for allowing adipogenesis to proceed
Localization revealed epithelial-mesenchymal interactions, differentiation differences within the retinoic acid biosynthesis and signaling pathway, and observations on nuclear versus cytoplasmic locations of Crabp2 and RA receptors (alpha, beta, gamma).
Increases in CRABPI and II transcripts in the absence of leukemia inhibitory factor may regulate aspects of embryonic stem cell differentiation in response to retinol.
TIS7 inhibits CRABP II expression during axonal regeneration, thereby modulating retinoic acid signalling. Hence, neurite initiation and branching are regulated by a negative feedback mechanism involving TIS7 and CRABP II.
This gene encodes a member of the retinoic acid (RA, a form of vitamin A) binding protein family and lipocalin/cytosolic fatty-acid binding protein family. The protein is a cytosol-to-nuclear shuttling protein, which facilitates RA binding to its cognate receptor complex and transfer to the nucleus. It is involved in the retinoid signaling pathway, and is associated with increased circulating low-density lipoprotein cholesterol. Alternatively spliced transcript variants encoding the same protein have been found for this gene.
cellular retinoic acid-binding protein 2 , etID50793.16 , cellular retinoic acid binding protein 2 , CRABP-II , cellular retinoic acid-binding protein II , cellular lipid-binding protein , cellular retinoic acid binding protein II
GENE ID | SPECIES |
---|---|
378522 | Xenopus laevis |
171480 | Danio rerio |
469838 | Pan troglodytes |
100155151 | Sus scrofa |
493998 | Bos taurus |
448629 | Xenopus (Silurana) tropicalis |
612093 | Canis lupus familiaris |
718579 | Macaca mulatta |
1382 | Homo sapiens |
29563 | Rattus norvegicus |
100358958 | Oryctolagus cuniculus |
12904 | Mus musculus |
100857929 | Gallus gallus |
100724780 | Cavia porcellus |